It was found that the TGF-β1 pathway, AMPK signaling pathway, insulin-related signaling pathway, lipid metabolism, and TNF-α pathway were the major pathways of treatment of GDC for diabetic nephropathy. This evidence concerns the gene INS and diabetic kidney disease.